No retraction, correction or concern found when last checked on Oct 19, 2026.
Risk of Incident Diabetes in Relation to Long-term Exposure to Fine Particulate Matter in Ontario, Canada
Hong Chen, Richard T. Burnett, Jeffrey C. Kwong and 8 more
Environmental Health Perspectives · 2013 · Public domain
Abstract
Background: Laboratory studies suggest that fine particulate matter (≤ 2.5 µm in diameter; PM2.5) can activate pathophysiological responses that may induce insulin resistance and type 2 diabetes. However, epidemiological evidence relating PM2.5 and diabetes is sparse, particularly for incident diabetes. Objectives: We conducted a population-based cohort study to determine whether long-term exposure to ambient PM2.5 is associated with incident diabetes. Methods: We assembled a cohort of 62,012 nondiabetic adults who lived in Ontario, Canada, and completed one of five population-based health surveys between 1996 and 2005. Follow-up extended until 31 December 2010. Incident diabetes diagnosed between 1996 and 2010 was ascertained using the Ontario Diabetes Database, a validated registry of persons diagnosed with diabetes (sensitivity = 86%, specificity = 97%). Six-year average concentrations of PM2.5 at the postal codes of baseline residences were derived from satellite observations. We used Cox proportional hazards models to estimate the associations, adjusting for various individual-level risk factors and contextual covariates such as smoking, body mass index, physical activity, and neighborhood-level household income. We also conducted multiple sensitivity analyses. In addition, we examined effect modification for selected comorbidities and sociodemographic characteristics. Results: There were 6,310 incident cases of diabetes over 484,644 total person-years of follow-up. The adjusted hazard ratio for a 10-µg/m3 increase in PM2.5 was 1.11 (95% CI: 1.02, 1.21). Estimated associations were comparable among all sensitivity analyses. We did not find strong evidence of effect modification by comorbidities or sociodemographic covariates. Conclusions: This study suggests that long-term exposure to PM2.5 may contribute to the development of diabetes.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 20, 2026. Paragraph numbers are ours, so an answer can point at one.
Diabetes mellitus and its associated macrovascular and microvascular complications constitute a serious threat to global human health and welfare. The burden of diabetes relates particularly to type 2 diabetes, which accounts for 90–95% of cases globally. Although obesity, diet, and physical inactivity have been identified as important risk factors for type 2 diabetes, there is increasing evidence that insulin resistance, the underlying hallmark and pathophysiological mechanism leading to type 2 diabetes, can be aggravated by factors that promote inflammatory responses.
It is only recently that ambient air pollution has been implicated in the etiology of type 2 diabetes. Exposure to air pollution has been associated with cardiovascular-related mortality and morbidity. There is also evidence that persons with diabetes are particularly susceptible to the acute effects of air pollution. In a mouse model, exposure to fine particulate matter (particles with an aerodynamic diameter ≤ 2.5 µm; PM2.5) increased blood glucose and induced adipose inflammation and insulin resistance. This animal study provides a potential biological basis for the link between air pollution and diabetes.
Because of the ubiquitous nature of exposure to air pollution, even a modest effect of air pollution on increasing the risk of diabetes may pose a large public health burden. To date, only four epidemiological studies have investigated the relationship between air pollution and incident diabetes. Two reported positive associations between incident diabetes and PM2.5 and traffic-related pollutants such as nitrogen oxides (NOx) and nitrogen dioxide (NO2). However, another study reported no association between incident diabetes and PM2.5, and the fourth reported only a small increase in diabetes associated with NO2. Of the four cohort studies, one was based on a general population, two included women only, and one comprised female nurses and male health professionals.
Given that few epidemiological studies have examined associations between air pollution and diabetes, and because little is known about the association in the general population, we conducted a population-based cohort study of long-term exposure to PM2.5 and incident diabetes in Ontario, Canada.
Materials and Methods
Study design and population. The study was designed as a follow-up of respondents from Ontario, Canada, to the 1996/1997 cycle of National Population Health Survey of all Canadians and the 2000/2001, 2002, 2003, and 2005 cycles of the Canadian Community Health Surveys among Canadians ≥ 12 years of age. These population-based surveys collected information related to health status, health care utilization, and determinants of health for the Canadian population in all provinces and territories, excluding full-time members of the Canadian military, institutional residents, and individuals living on Indian Reserves, Crown Lands, and certain remote regions. The same questions were used across surveys. The response rates of the surveys in Ontario varied from 73.4 to 92.8%, depending on the year. The surveys have been used in health research, such as estimating the burden of cardiovascular diseases in Canada.
The study population for the present analysis comprised all respondents who, at the time of survey, resided in Ontario, were ≥ 35 years of age, were registered with Ontario’s provincial health insurance plan, provided informed consent to share and link their responses to provincial health administrative data, and were free of diabetes. In addition, we restricted our analyses to Canadian-born individuals, because immigrants to Canada have unknown prior exposures and tend to have better health and health behaviors, but are more likely to live in areas with higher ground-level concentrations of PM2.5 than those born in Canada. A total of 62,012 participants were included in the study and they were followed-up from the time of survey until 31 December 2010.
The study was approved by the Research Ethics Board of Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada.
Ascertainment of diabetes and other comorbidities. We used the Ontario Diabetes Database (Toronto, ON, CA), a validated registry of diabetics in Ontario, to identify cohort members with and without diabetes. This database was developed using hospital discharge abstracts from the Canadian Institute for Health Information and physician service claims from the Ontario Health Insurance Plan database (Toronto, ON, CA). The hospital discharge database captures all hospital admissions among Ontario residents, whereas the claims database includes claims from approximately 98% of Ontario physicians because of the universal nature of the provincial medicare system.
Individuals were entered in the diabetes database if they had at least one hospital admission with a diagnosis of diabetes [International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9CM; ) diagnostic code 250 or 10th Revision (ICD-10; ) code E10–E14 after 2002] or two or more physician claims for diabetes (code 250) within a 2-year period. Gestational diabetes was excluded. This algorithm has been validated using chart review and shown to have high sensitivity (86%) and specificity (97%) for identifying persons with diabetes. More recently, a study evaluating medical records of 22 family practitioners and their patients in southwestern Ontario confirmed the high sensitivity and specificity of this algorithm. Once included in the database, individuals remain in it until death or termination of Ontario health coverage. The eligibility of cohort members for health insurance and their vital status through the follow-up period were assessed using data from the Registered Persons Database (Toronto, ON, CA), a registry of all Ontario residents who have a health insurance number.
We linked the 62,012 cohort members to the diabetes database using encrypted health insurance numbers. We defined incident diabetes as cases diagnosed between the time of entry into the cohort and the end of follow-up (31 December 2010). Prevalent cases of diabetes diagnosed before the baseline survey were excluded from the analyses.
In addition, we determined whether participants had any of the following comorbidities at baseline: hypertension, congestive heart failure, acute myocardial infarction, asthma, and chronic obstructive pulmonary disease (COPD). These five comorbidities are often present in diabetic patients. We ascertained the five comorbidities using validated registries based on hospital discharge abstracts and physician service claims in Ontario [see Supplemental Material, Comorbidity Ascertainment, pp. 3–4 (http://dx.doi.org/10.1289/ehp.1205958)] (,;; Tu JV et al. 2001; Tu K et al. 2008).
Assessment of long-term exposure to PM2.5. To assess long-term exposure to ambient air pollution, we used satellite-based estimates of surface concentrations of PM2.5. The satellite-based concentrations were derived from aerosol optical depth data from the Moderate Resolution Imaging Spectroradiometer (MODIS) and Multiangle Imaging Spectroradiometer (MISR) instruments onboard the National Aeronautics and Space Administration (NASA)’s Terra satellite. Using satellite data collected from 1 January 2001 through 31 December 2006, we derived long-term average concentrations of PM2.5 at a resolution of approximately 10 × 10 km and covered all North America below 70°N, which includes all of Ontario. These satellite-based long-term average concentrations of PM2.5 have been shown to correlate well with ground measurements at fixed-site stations across North America (Pearson correlation coefficient r = 0.77, n = 1057). These satellite-based estimates have been applied previously to estimate associations between long-term exposure to air pollution and mortality and to estimate the global burden of illnesses due to air pollution. The remote sensing methodology used to estimate ground-level ambient concentrations of PM2.5 have been described in detail elsewhere. We assigned exposure by linking the exposure surface concentrations of PM2.5 to subjects’ residences at cohort entry using six-character postal codes. Six-character postal codes in urban areas represent the centroid of the blocks in which the cohort members lived.
Potential confounding variables. From the self-reported health surveys, we extracted information on marital status, race/ethnicity (white, black, Asian, Arab, Latin American, other), education attainment (less than high school, high school, some postsecondary, and university), and household income adequacy (lowest income, lower middle income, middle income, upper middle income, and upper income). Household income adequacy is an index used by Statistics Canada that accounts for total household income and household size. Because 98% of the cohort was classified as white, we dichotomized race/ethnicity as white or nonwhite.
In addition, we extracted baseline survey data for height and weight to calculate body mass index (BMI; kilograms per meter squared). We also obtained information on smoking status (never smoker, current smoker, former smoker), alcohol consumption (more than once a month, less than once a month, former drinker, never drank), daily consumption of fruits and vegetables (< 5 servings/day, ≥ 5 servings/day), physical activity (≥ 3.0, 1.5–2.9, < 1.5 kcal/kg/day of energy expenditure for leisure activities), and urban/rural residence. Urban areas are those continuously built-up areas having a population ≥ 1,000 and a population density ≥ 400/km2 based on current census population counts.
Using the Canadian Census data for 1996, 2001, and 2006, we created contextual variables at the census tract level for the proportion of population ≥ 15 years of age with less than high school education, unemployment rate, and mean household income. Because census tracts are not defined for rural areas, we derived these three variables for rural residents according to their census subdivision, which is the next higher geographic unit, usually representing a municipality or equivalent. We assigned the values of contextual variables derived from the 1996/1997 census for individuals who entered the cohort in 1996; from the 2001 census for individuals who entered in 2000/2001, 2002, or 2003; and from the 2006 census for individuals who entered in 2005. Census tracts are small and relatively homogeneous geographic units that usually comprise a population of 2,500–8,000.
To control for regional-scale spatial patterns in the incidence of diabetes that could be explained by factors other than pollution, we created a dichotomous indicator variable classifying Ontario into southern and northern regions based on the 14 Ontario Local Health Integrated Networks. The Local Health Integrated Networks are responsible for planning, integrating, and funding various local health care services in Ontario.
Statistical analysis. We used a stratified Cox proportional hazards model with strata defined as single-year age groups, cycle of survey, and region (south/north). We excluded 1,936 individuals with missing data for BMI, and we created for all other covariates a separate category for missing values, leaving 60,076 cohort members in all analyses.
The outcome was the incident diagnosis date of diabetes as indicated in the diabetes database. Follow-up time was measured in days, calculated from the date of interview until the date of incident diabetes, or death, or were no longer eligible for provincial health insurance, or until the end of follow-up (31 December 2010).
We modeled associations between PM2.5 and incident diabetes, adjusting for sex, marital status, education, household income adequacy, race/ethnicity, BMI (a linear term and a quadratic term), physical activity, smoking, drinking, diet, urban residency, hypertension at baseline, area-level unemployment, education, and mean household income at baseline. In separate analyses we also controlled for other comorbidities including congestive heart failure, acute myocardial infarction, COPD, and asthma.
We routinely tested for deviations from the proportional hazards assumption by assessing whether the cross-product of each variable with the natural logarithm of the time variable was statistically significant (α = 0.05). We also verified the assumption of linearity for PM2.5 and all other continuous variables by using natural cubic spline functions with two and three degrees of freedom. We examined plots of the concentration–response curves and used the Akaike Information Criterion (AIC) to assess the relative goodness of fit for these models. A difference of > 4 AIC points is considered to prefer one model over another. Because there was no evidence of departure from linearity for the relation of PM2.5 and diabetes, we report adjusted hazard ratios (HR) and 95% CIs for every 10-µg/m3 increase of PM2.5 (referred to as HR10). We chose an increment of 10 µg/m3 to facilitate comparisons of our findings with other studies.
In addition, we investigated potential effect modification by age, sex, BMI, education, race/ethnicity, household income adequacy, physical activity, smoking, and comorbidities by assessing whether the interaction term that was the cross-product of each variable with PM2.5 value was statistically significant.
Sensitivity analyses. Our main analysis focused on exposure assigned according to residential postal codes at cohort entry. To assess the impact of residential mobility on the effect estimates, we performed three sensitivity analyses by restricting the follow-up period to first 2 or 5 years, respectively; restricting to 55,708 participants who had lived at their baseline address for at least 5 years before baseline; and modeling time-weighted exposure since cohort entry until the event, with weights for each participant defined by the time spent at each address. For the latter analysis, we obtained residence for each subject and each year from the Registered Persons Database (Toronto, ON, CA) for the period 1996–2010, and derived annual estimates of PM2.5 exposure by assigning the 6-year mean concentration of PM2.5 at each annual postal code.
We also performed additional sensitivity analyses by restricting to participants who had used health services 1–2 years before the baseline because of a concern that the frequency of health care utilization might influence the likelihood of detecting diabetes; excluding participants with missing information on diet because two of the five surveys (1996 and 2002; 27% of the study population) did not include diet-related questions; excluding participants from the 2002 cycle of health survey because this survey had the lowest response rate (73.4%); and restricting the analysis to southern Ontario, where 83% of the cohort lived.
We next investigated whether the association might be influenced by spatial dependence among study subjects. We fitted the Cox model with a frailty (random effect) term for Ontario Local Health Integration Networks to allow for the possibility that the effect estimate for diabetes may vary from network to network in the estimation of the main effect and its variance. A gamma distribution for the frailties was assumed, with an exchangeable correlation structure within network. We compared models with and without a frailty term using the AIC. We repeated this analysis by using a frailty term for grids from PM2.5 exposure surface (10 × 10 km) as a random effect.
Furthermore, we examined whether associations changed over time by additionally adjusting the Cox model for annual mean concentration of PM2.5 in Ontario (as a linear term) for the period 1996–2010. We derived the long-term trend of PM2.5 using data from all air quality monitoring stations across Ontario that operated for at least half of the study period [see Supplemental Material, Figure S1 (http://dx.doi.org/10.1289/ehp.1205958)]. We also tested for interactions between time periods (1996–2000 and 2007–2010) and PM2.5.
Results
The cohort comprised 484,644 person-years of observations. Mean (± SD) follow-up was 8 ± 3.2 years. The mean age of the cohort at time of entry was 54.9 years (Table 1). Forty–five percent of the cohort members were men, 63% were married, 24% were current smokers, and 54% were either overweight or obese (BMI ≥ 25 kg/m2). In addition, 29% of the cohort had hypertension, 10% had COPD, and 3% had congestive heart failure at baseline. Average unemployment among the census tracts was 7%, and mean household income was approximately Can$62,300.
Of the cohort, 17%, 26%, 8%, 25%, and 24% were enrolled from the surveys of 1996/1997, 2000/2001, 2002, 2003, and 2005, respectively. Among cohort members of the five surveys, we identified 1,503, 1,697, 495, 1,474, and 1,141 incident cases of diabetes during the follow-up, with a total of 6,310 cases. Average estimated exposure to PM2.5 during 2001–2006 was 10.6 µg/m3 (range, 2.6–19.1 µg/m3), with the highest average concentrations in southern Ontario (Figure 1).
Associations between diabetes and PM2.5. For every 10-µg/m3 increase of PM2.5, the hazard ratio for incident diabetes (HR10) was 1.08 (95% CI: 0.99, 1.17) adjusting for sex and stratifying on age, survey year, and region (Table 2). Adjustment for education, household income, and BMI strengthened the association between PM2.5 and diabetes (HR10 -~⊇1.12). Additionally controlling for physical activity, smoking, and other individual-level covariates did not appreciably change the HR. In the fully adjusted model that included all individual-level covariates, contextual covariates, and comorbid conditions, the HR10 was 1.11 (95% CI: 1.02, 1.21). Modeling PM2.5 using natural splines did not improve model fit according to AIC relative to the model that assumed linearity for PM2.5 (AIC = 57441 for the model with a linear term of PM2.5; AIC = 57442 for the model with natural spline), suggesting a potential log-linear relationship between PM2.5 and incident diabetes [see Supplemental Material, Figure S2 (http://dx.doi.org/10.1289/ehp.1205958)].
We observed larger HRs between diabetes and PM2.5 among 819 participants with preexisting COPD (HR10 = 1.33; 95% CI: 1.03, 1.71 compared with HR10 = 1.08; 95% CI: 0.98, 1,18 for those without COPD; p-interaction = 0.13), and among women (HR10 = 1.17; 95% CI: 1.03, 1.32 compared with HR10 = 1.03; 95% CI: 0.91, 1.16 for men; p-interaction = 0.15), and participants < 50 or > 65 years of age compared with 50–65 years (p-interaction = 0.19) (Table 3).
Sensitivity analyses. Restricting the analysis to the first 2 and 5 years of follow-up slightly increased the effect estimates for diabetes (Table 4). Using time-weighted exposure as an alterative exposure metric did not result in appreciable difference in the estimate of association. In addition, the risk estimate was insensitive to exclusion of participants who had recently moved to their baseline addresses before the study, those who had not used health services within the previous 2 years, those who enrolled in the 2002 survey, or those who lived in northern Ontario. Additionally, we excluded participants with missing information on diet, yielding an HR10 of 1.10 (95% CI: 0.96, 1.23). Furthermore, adding a frailty term to allow for random effects according to Ontario Local Health Integration Networks or grids from PM2.5 exposure surface had little impact on the HR or its variance. Last, there was no strong evidence of variation in the estimated effects of PM2.5 over time, and the test for interactions between periods and PM2.5 was not statistically significant (p-interactions = 0.95 and 0.35).
Discussion
In this population-based cohort study of 62,012 adults in Ontario, we found that long-term exposure to PM2.5 was associated with an increased risk of incident diabetes after controlling for various individual and neighborhood covariates. The estimate of association was insensitive to various sensitivity analyses. Additionally, we did not find strong evidence for effect modification by selected comorbidities and sociodemographic covariates.
This study provides evidence for the association between incident diabetes and PM2.5. Few studies have investigated the relationship between incident diabetes and air pollution. In a study of 1,775 women in the Ruhr district of Germany, reported an adjusted HR of 1.27 (95% CI: 1.09, 1.48) for incident diabetes for every interquartile-range (IQR) increase of PM2.5 (IQR = 0.4/105 m using absorbance-based measurement) and 1.42 (95% CI: 1.16, 1.73) per IQR of NO2 (IQR = 8 ppb). A second study of 4,204 African-American women in Los Angeles, California, reported an HR of 1.25 (95% CI: 1.07, 1.46) per IQR of NOx (12.4 ppb) and 1.63 (95% CI: 0.78, 3.44) for a 10-µg/m3 increase in PM2.5.
In contrast, there was little evidence of an association between incident diabetes and particulate pollutants [PM2.5, PM2.5–10, PM10 (PM with diameter 2.5–10 µm and ≤ 10 µm)] in a cohort of female nurses (n = 74,412) or a cohort of male health professionals (n = 15,048) living in metropolitan areas of the northeastern and midwestern United States, though residential proximity to roadways was associated with diabetes among the nurses (0–49 m vs. ≥ 200 m: HR = 1.14; 95% CI: 1.03, 1.27). In a study of 51,818 participants in Denmark, an IQR increase in NO2 (2.6 ppb) was not associated with all cases of diabetes (HR = 1.00; 95% CI: 0.97, 1.04), but was associated with cases who were identified using a more strict case definition (HR = 1.04; 95% CI: 1.00, 1.08). Finally, there was a 4% increase in the adjusted odds (95% CI: 0%, 8%) of diabetes prevalence with each parts per billion increase of NO2 among women in a cross-sectional study of respiratory clinic patients in Hamilton and Toronto, Ontario, but there was no association among men.
Although associations with diabetes in previous studies were relatively consistent for NO2, associations with PM2.5 were not. The inconsistency may be attributable to chance, differences in population characteristics, misclassification of exposure (resulting from different exposure methods across studies), or inherent differences in the toxicological properties of the pollutants. In these prior studies, positive associations were reported mostly among women, and we also found a stronger association among women than men. This stronger association could be attributable to chance, but it may also reflect smaller errors in exposure assessment for women, because women tend to spend more time in and around home than men. Physiological and lifestyle differences may also contribute to the difference in effect estimates between men and women. Associations also varied by age, with stronger effects of PM2.5 among those above and below 50–65 years of age at baseline. However, our data are inadequate to investigate this pattern further.
Although increasing BMI is a strong risk factor for diabetes, our results do not support the idea that being overweight or obese would enhance susceptibility to the effects of air pollution on diabetes. We did not find strong evidence suggesting that other comorbidities materially altered the association between PM2.5 and diabetes, though power to detect differences was limited. Because inflammation is a key feature of common chronic diseases such as COPD and an important pathophysiological response to PM2.5 exposure, further investigation is needed on whether the chronic state of inflammation in patients with these conditions may heighten their susceptibility to diabetes as a consequence of PM2.5 exposure.
To our knowledge, this is the largest study of incident diabetes in a population-based cohort to date. According to the Canadian Census in 2001, this cohort is representative of the Canadian-born population ≥ 35 years of age in Ontario (mean age = 53.3, men = 48%, married = 65%, and white = 99%). We obtained extensive individual information on known risk factors, and the diagnosis of diabetes was based on a validated registry with very high sensitivity and specificity. Finally, the use of satellite-based long-term average estimates of PM2.5 ensures virtually complete spatial coverage of PM2.5 among all cohort members. The satellite-based estimates have been shown to correlate well with ground-based measurements. The ambient level of PM2.5 in Ontario (annual mean in 2000, 11.2 µg/m3) was much lower than average exposures in previous studies conducted in Los Angeles, California (annual mean PM2.5 in 2000, 20.7 µg/m3) and in the Ruhr district of Germany (annual mean PM2.5 in 2002, 22.4 µg/m3).
This study has several limitations that should be considered. First, we could not differentiate between type 1 and type 2 diabetes. However, given that type 2 diabetes accounts for > 90% of all diabetes cases globally and that all cohort members were ≥ 35 years of age at entry (mean, ~ 55 years), the vast majority of incident diabetes in this cohort is expected to be type 2 diabetes.
Second, we could not identify undiagnosed cases of diabetes in the cohort. Although incomplete diagnosis of cohort members is a potential limitation of this study, effect estimates were virtually unchanged when we restricted the analysis to subjects who had used health care services during the 1–2 years before baseline as a proxy indicator of health care utilization, which may be related to the diagnosis of diabetes. Because of universal health care in Ontario, it is expected that we may have underestimated the true effects because this measurement error was likely independent of the exposure.
Third, the spatial pattern in exposure used was derived for the period 2001 to 2006 only. However, the spatial gradients of ambient PM2.5 in Ontario remained stable during the follow-up period (1996–2010) and that variability in the concentrations of PM2.5 is primarily spatial in nature and not temporal [see Supplemental Material, p. 4 (http://dx.doi.org/10.1289/ehp.1205958)]. Studies conducted in diverse locations across the United States have also demonstrated long-term stability in the spatial patterns of PM2.5. We therefore expect that the spatial contrasts in PM2.5 during 2001–2006 is a reasonable representation of longer-term spatial exposure to PM2.5 in Ontario. The spatial resolution of PM2.5 exposure surface (i.e., 10 × 10 km), however, meant that we were unable to estimate associations at finer spatial scale. We also did not have information on daily activity. To assess the impact of residential mobility, we performed various sensitivity analyses, which did not result in appreciable differences in risk estimates. Also, our analyses did not consider the mixture of air pollutants to which subjects may have been exposed.
Fourth, we did not have family history of diabetes or occupational exposure to dust/fumes in the surveys, and information on potential confounding variables was obtained at baseline only. Twenty-seven percent of the cohort had missing information on diet which was modeled as a separate category. However, there was little change in the association between PM2.5 and diabetes when we excluded members with missing information on diet.
This study suggests that long-term exposure to PM2.5 may contribute to the development of diabetes. A plausible biological mechanism linking exposure to PM2.5 with diabetes may be indirect effects mediated through systemic proinflammatory and oxidative responses. found that exposing mice to ambient PM2.5 at the concentration of 72 µg/m3 for 6 hr each day over 10 weeks exacerbated insulin resistance by enhancing systemic inflammatory response and inflammation in adipose tissue. Other plausible mechanisms include autonomic nervous system imbalance and endothelial dysfunction that may be triggered by PM2.5, which would in turn induce vasoconstriction and result in reduced insulin sensitivity.
Conclusions
In summary, we investigated the association between long-term exposure to PM2.5 and the risk of incident diabetes in a large cohort in Ontario, Canada. Results from this study support a possible relationship between PM2.5 and diabetes.
References 49
- 1.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;33:S62-S69.
Not in our library10.2337/dc11-s062
- 2.
Andersen ZJ, Raaschou-Nielsen O, Ketzel M, Jensen SS, Hvidberg M, Loft S, et al. Diabetes incidence and long-term exposure to air pollution. Diabetes Care. 2012;35:92-98.
Not in our library10.2337/dc11-1155
- 3.
Brauer M, Amann M, Burnett R, Cohen A, Dentener F, Ezzati M, et al. Exposure assessment for estimation of the global burden of disease attributable to outdoor air pollution. Environ Sci Technol. 2012;46:652-660.
Not in our library10.1021/es2025752
- 4.
Brook RD, Jerrett M, Brook JR, Bard RL, Finkelstein MM. The relationship between diabetes mellitus and traffic-related air pollution. J Occup Environ Med. 2008;50:32-38.
Not in our library10.1097/jom.0b013e31815dba70
- 5.
Brook RD, Rajagopalan S, Pope CA, Brook JR, Bhatnagar A, Diez-Roux AV, et al. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121:2331-2378.
Not in our library10.1161/cir.0b013e3181dbece1
- 6.
ICD-9-CM Addenda, Conversion Table, and Guidelines. 2012.
Not in our library
- 7.
Supply of Physicians’ Services in Ontario. Toronto:Institute for Clinical Evaluative Sciences. 1999.
Not in our library
- 8.
Chen H, Goldberg MS, Villeneuve PJ. A systematic review of relation between long-term exposure to ambient air pollution and chronic diseases. Rev Environ Health. 2008;23:243-296.
Not in our library10.1515/reveh.2008.23.4.243
- 9.
Colditz GA, Willett WC, Rotnitzky A, Manson JAE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481-486.
Not in our library10.7326/0003-4819-122-7-199504010-00001
- 10.
Coogan PF, White LF, Jerrett M, Brook RD, Su JG, Seto E, et al. Air pollution and incidence of hypertension and diabetes mellitus in black women living in Los Angeles: clinical perspective. Circulation. 2012;125:767-772.
Not in our library10.1161/circulationaha.111.052753
- 11.
- 12.
Drury PL. Diabetes and arterial hypertension. Diabetologia. 1983;24:1-9.
Not in our library10.1007/bf00275938
- 13.
Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370:797-799.
Not in our library10.1016/s0140-6736(07)61383-x
- 14.
Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying individuals with physcian diagnosed COPD in health administrative databases. COPD. 2009a;6:388-394.
Not in our library10.1080/15412550903140865
- 15.
Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying patients with physician-diagnosed asthma in health administrative databases. Can Respir J. 2009b;16:183-188.
Not in our library10.1155/2009/963098
- 16.
Goldberg MS, Burnett RT, Yale JF, Valois MF, Brook JR. Associations between ambient air pollution and daily mortality among persons with diabetes and cardiovascular disease. Environ Res. 2006;100:255-267.
Not in our library10.1016/j.envres.2005.04.007
- 17.
Harris SB Richard G Jordan T Andrew W Vijaya C Moira S 2010 Investigating concordance in diabetes diagnosis between primary care charts (electronic medical records) and health administrative data: a retrospective cohort study.BMC Health Serv Res10347;[Online 23 December 2010]
Not in our library10.1186/1472-6963-10-347
- 18.
Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-867.
Not in our library10.1038/nature05485
- 19.
Hu FB, Manson JAE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345:790-797.
Not in our library10.1056/nejmoa010492
- 20.
Hux JE, Ivis F, Flintoft V, Bica A. Determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002;25:512-516.
Not in our library10.2337/diacare.25.3.512
- 21.
Jerrett M, Burnett RT, Ma R, Pope CA, Krewski D, Newbold KB, et al. Spatial analysis of air pollution and mortality in Los Angeles. Epidemiology. 2005;16:727-736.
Not in our library10.1097/01.ede.0000181630.15826.7d
- 22.
Kannel WB, McGee DL. Diabetes and cardiovascular disease. JAMA. 1979;241:2035-2038.
Not in our library10.1001/jama.241.19.2035
- 23.
- 24.
Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure. JAMA. 2003;290:2581-2587.
Not in our library10.1001/jama.290.19.2581
- 25.
Leffondre K, Abrahamowicz M, Siemiatycki J, Rachet B. Modeling smoking history: a comparison of different approaches. Am J Epidemiol. 2002;156:813-823.
Not in our library10.1093/aje/kwf122
- 26.
Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995 to 2005: a population-based study. Lancet. 2007;369:750-756.
Not in our library10.1016/s0140-6736(07)60361-4
- 27.
Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32:962-969.
Not in our library10.1183/09031936.00012408
- 28.
Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991a;151:1141-1147.
Not in our library
- 29.
Manson JE, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Hennekens CH, et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet. 1991b;338:774-778.
Not in our library10.1016/0140-6736(91)90664-b
- 30.
Manuel DG, Leung M, Nguyen K, Tanuseputro P, Johansen H. Burden of cardiovascular disease in Canada. Can J Cardiol. 2003;19:997-1004.
Not in our library
- 31.
McDonald JT, Kennedy S. Insights into the healthy immigrant effect: health status and health service use of immigrants to Canada. Soc Sci Med. 2004;59:1613-1627.
Not in our library10.1016/j.socscimed.2004.02.004
- 32.
Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, et al. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 2007;356:447-458.
Not in our library10.1056/nejmoa054409
- 33.
O'Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR, Economides PA, et al. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation. 2005;111:2913-2920.
Not in our library10.1161/circulationaha.104.517110
- 34.
Pope CA, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002;287:1132-1141.
Not in our library10.1001/jama.287.9.1132
- 35.
- 36.
Rana JS, Mittleman MA, Sheikh J, Hu FB, Manson JAE, Colditz GA, et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care. 2004;27:2478-2484.
Not in our library10.2337/diacare.27.10.2478
- 37.
National Population Health Survey – Household Component – Longitudinal (NPHS). 2010a.
Not in our library
- 38.
Canadian Community Health Survey – Annual Component (CCHS). 2010b.
Not in our library
- 39.
1996 Census of Canada. 2012a.
Not in our library
- 40.
2001 Census of Canada. 2012b.
Not in our library
Cited by papers we hold 9
- Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019 · 2022No notice
- Obesity and the relation between joint exposure to ambient air pollutants and incident type 2 diabetes: A cohort study in UK Biobank · 2021No notice
- Environmental Risk Factors for Developing Type 2 Diabetes Mellitus: A Systematic Review · 2018No notice
- In Vitro and In Vivo Experimental Studies of PM2.5 on Disease Progression · 2018No notice
- Association of Long-Term Exposure to Transportation Noise and Traffic-Related Air Pollution with the Incidence of Diabetes: A Prospective Cohort Study · 2017No notice
- Associations of Residential Long-Term Air Pollution Exposures and Satellite-Derived Greenness with Insulin Resistance in German Adolescents · 2016No notice
- Exposure to Fine Particulate Air Pollution Causes Vascular Insulin Resistance by Inducing Pulmonary Oxidative Stress · 2016No notice
- Association between Ambient Air Pollution and Diabetes Mellitus in Europe and North America: Systematic Review and Meta-Analysis · 2015No notice
- Long-term exposure to fine particulate matter and incidence of type 2 diabetes mellitus in a cohort study: effects of total and traffic-specific air pollution · 2015Corrected
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.